Mycobacteraemia among HIV-1-infected patients i São Paulo, Brazil: 1995 to 1998

Epidemiology and Infection

Volumn 132, Issue 1, 2004, Pages 151-155

  Hadad, D J ^a   Palaci, M ^a   Pignatari, A C C ^b   Lewi, D S ^b   Machado, M A S ^b   Telles, M A S ^c   Martins, M C ^c   Ueki, S Y M ^c   Vasconcelos, G M ^d   Palhares, M C A ^d  

^a Department of Electrical Engineering   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

^d Centro de Ref/Treinamento AIDS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL VIRULENCE; BLOOD CULTURE; BRAZIL; CONTROLLED STUDY; FREQUENCY ANALYSIS; HEALTH CARE FINANCING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; MAJOR CLINICAL STUDY; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PUBLIC HOSPITAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BRAZIL; HIV-1; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; POPULATION SURVEILLANCE; RISK FACTORS; SEROTYPING; TUBERCULOSIS; URBAN HEALTH;

EID: 10744231574     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803001535     Document Type: Article

References (22)

1. Ministério da Saúde. Fundação Nacional de Saúde. Centro de Referência Prof. Hélio Fraga. Sociedade Brasileira de Pneumologia e Tisiologia. Controle da tuberculose: uma proposta de integração ensinoserviço. 2002. 5. ed. - Rio de Janeiro.
2. Barreto JA, Palaci M, Ferrazoli L, et al. Isolation of Mycobacterium avium complex from bone marrow aspirates of AIDS patients in Brazil. J Infect Dis 1993; 168: 777-779.
3. Barber TW, Craven DE, McCrabe WR. Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) 1990; 69: 375-376.
4. Horsburgh Jr CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324: 1332-1338.
5. Hadad DJ, Palhares MCA, Placco ALN, et al. Mycobaterium avium complex (MAC) isolated from AIDS patients and the criteria required for its implication in disease. Rev Inst Med Trop São Paulo 1995; 37: 375-383.
6. Grinsztejn B, Fandinho FCO, Veloso VG, et al. Mycobacteremia inpatients with the Acquired Immunodeficiency Syndrome. Arch Intern Med 1997; 157: 2359-2363.
7. + percentage in HIV-infected persons. JAMA 1993; 269: 622-626.
8. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36: S3-S14.
9. David H, Lévy-Frébault V, Thorel MF. Méthodes de laboratorie pour mycobacteriologie clinique. Paris: Institut Pasteur, Unité de la Tuberculose et des mycobacteries, 1989: 87 pp.
10. Kent PT, Kubica GP. Public health mycobacteriology - a guide for level III laboratory. Atlanta: Centers for Disease Control, 1985 (PB 86 - 216546).
11. Tsukamura M. Screening for atypical mycobacteria. Tubercle 1970; 51: 280-284.
12. Agy MB, Wallis CK, Plorde JJ, et al. Evaluation of four mycobacterial blood culture media: BACTEC 13A, Isolator/BACTEC 12B, Isolator/Middlebrook agar, and a biphasic medium. Diagn Microbiol Infect Dis 1989; 12: 303-308.
13. von Reyn CF, Arbeit RD, Tosteson AN, et al. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. AIDS 1996; 10: 1025-1032.
14. Gilks CF, Brindle RJ, Mwachari C, et al. Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 195-198.
15. Barnes PF, Bloch AB, Davidson PT, Snider Jr DE. Tuberculosis in patients with human immunodeficiency virus infection. New Engl J Med 1991; 324: 1644-1650.
16. Rook GAW, Bloom BR. Mechanisms of pathogenesis in tuberculosis. In: Bloom BR, ed. Tuberculosis - pathogenesis, protection and control. Washington, DC: ASM Press, 1994: 485-501, chapter 28.
17. von Reyn CF. The significance of bacteremic tuberculosis among persons with HIV infection in developing countries [Editorial]. AIDS (England) 1999; 13: 2193-2195.
18. Brasil. Ministério da Saúde. Lei no. 0.313 de 13 de novembro de 1996. Dispõe sobre a distribuição gratuita de medicamentos aos portadores de HIV e doentes de AIDS. Diário Oficial da República Federativa do Brasil. Brasília: n. 126, pp. 14122-14129. 14 Nov. 1996. Seção 1.
19. Hadad DJ, Lewi DS, Pignatari ACC, et al. Resolution of Mycobacterium avium complex bacteremia following highly active antiretroviral therapy. Clin Infect Dis 1998; 26: 758-759.
20. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new anti-retrovirals. Lancet 1997; 49: 1294.
21. Palella Jr FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
22. Espinal MA, Reingold AL, Koenig E, et al. Screening for active tuberculosis in HIV testing centre. Lancet 1995; 345: 890-893.